Spiegelman Daniel K is a director of Myriad Genetics, Inc.
Person profile
Roles
Address
Salt Lake City, Utah
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
3
Kyverna Therapeutics, Inc.
7 Feb 24
4
MYRIAD GENETICS INC
2 Jun 23
144
MYRIAD GENETICS INC
2 Jun 23
4
SPRUCE BIOSCIENCES, INC.
26 May 23
4
MYRIAD GENETICS INC
6 Jun 22
4
MYRIAD GENETICS INC
3 Jun 22
4
SPRUCE BIOSCIENCES, INC.
27 May 22
4
MYRIAD GENETICS INC
17 Jun 21
4
MYRIAD GENETICS INC
4 Jun 21
4
MYRIAD GENETICS INC
1 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jun 23 | MYGN Myriad Genetics | Common Stock | Sell | Dispose S | No | Yes | 23.01 | 8,638 | 198.76 k | 40,493 |
1 Jun 23 | MYGN Myriad Genetics | Common Stock | Grant | Acquire A | No | No | 0 | 15,151 | 0.00 | 49,131 |
25 May 23 | SPRB Spruce Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 2.26 | 30,000 | 67.80 k | 30,000 |